Well done for DYOR and in the end that's probably the number one thing to do at this end of the market.
And I am pretty sure most suffers will not use such a device.
I thought however the target market was those women whose problem was such that they sort out a clinician. ?
Where not the original figures touted based on 1% of the 15% who said they would use such a device?
I cant look it up atm so don't take my word for it.
Cheers
Oscar
- Forums
- ASX - By Stock
- ALT
- setting sales goal
setting sales goal, page-12
Featured News
Add ALT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online